insights_auto
Why is INO down 21,26%?
Dive Deeperchevron_right
INO:NASDAQ
Inovio Pharmaceuticals Inc
0,80 USD
arrow_downward
-21,26%(-0,21) 1D
0,79 USD
arrow_downward
-0,67% (-0,0053)todayPre-market
Closed: 21-окт., 16:00:01 GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for INO...
Open
1,06 USD
High
1,09 USD
Low
0,80 USD
Mkt. cap
82,23 млн
Avg. vol.
3,09 млн
Volume
33,13 миң
52-wk high
2,72 USD
52-wk low
0,57 USD
EPS
-1,17 USD
Beta
1,61
Shares outstanding
103,40 млн
No. of employees
112
Open
1,06 USD
High
1,09 USD
Low
0,80 USD
Mkt. cap
82,23 млн
Avg. vol.
3,09 млн
Volume
33,13 миң
52-wk high
2,72 USD
52-wk low
0,57 USD
EPS
-1,17 USD
Beta
1,61
Shares outstanding
103,40 млн
No. of employees
112
News stories
From web sources and news partners
News Corp
·
12 саат мурун
Inovio Pharmaceuticals Inc. stock underperforms Wednesday when compared to competitors
GuruFocus
·
1 күн мурун
Inovio Pharmaceuticals (INO) Awarded $80.4M in Legal Case Amid F
News Corp
·
1 күн мурун
Inovio Pharmaceuticals Inc. stock underperforms Tuesday when compared to competitors despite daily gains
Benzinga
·
1 күн мурун
12 Health Care Stocks Moving In Tuesday's After-Market Session
Profile
Inovio Pharmaceuticals, Inc. is an American biotechnology company focused on the discovery, development, and commercialization of synthetic DNA products for treating cancers and infectious diseases. In April 2020, Inovio was among some 100 companies, academic centers, or research organizations developing a vaccine candidate for treating people infected with COVID-19, with more than 170 total vaccine candidates in development. Wikipedia
About Inovio Pharmaceuticals Inc